Treatment at the highest observed-to-expected (O/E) hospitals was associated with independent and statistically significant improvement in ovarian cancer specific survival compared to intermediate O/E and lowest O/E hospitals, according to a study of 18,491 patients. Patients were treated at 405 hospitals with 37.3% receiving National Comprehensive Cancer Network (NCCN) ovarian cancer treatment adherent care. Study results indicated:
• Median survival was 38.9 months for lowest O/E hospitals, 50.5 months for intermediate O/E hospitals, and 53.8 months for highest O/E hospitals.
• Adherence to NCCN guidelines combined with minimum case volume criterion is correlated with improved survival and is a useful measure of quality care.
Citation: Galvan-Turner VB, Chang J, Ziogas A, Bristow RE, et al. Observed-to-expected adherence to treatment guidelines as a quality of care indicator for ovarian cancer. Gynecol Oncol. [Published online ahead of print September 24, 2015]. doi:10.1016/j.ygyno.2015.09.015.
This Week's Must Reads
Must Reads in Gynecologic Cancer
Maternal Factors in Cervical Cancer Prevention, Womens Health Issues; ePub 2019 Jan 10; Charlton, et al
Combined Gynecologic Ca & Pelvic Floor Dysfunction Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Oct 22; McConnell, et al